Downregulated pseudogene CTNNAP1 promote tumor growth in human cancer by downregulating its cognate gene CTNNA1

Xiangjian Chen1,2, Hua Zhu3, Xiaoli Wu4

  • 1Department of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, P.R. China.

Oncotarget
|August 4, 2016
PubMed

Insights

Pseudogene CTNNAP1 is dysregulated in colorectal cancer, correlating with tumor stage. Its overexpression inhibits cancer growth by regulating its cognate gene CTNNA1, offering a potential diagnostic biomarker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Deregulation of cancer-associated pseudogenes contributes to cancer development.
  • Pseudogenes are increasingly recognized for their roles in disease pathogenesis.

Purpose of the Study:

  • To investigate the role of pseudogene CTNNAP1 in colorectal cancer.
  • To elucidate the regulatory mechanism of CTNNAP1 and its cognate gene CTNNA1.
  • To explore the potential of CTNNAP1 as a diagnostic biomarker for colorectal cancer.

Main Methods:

  • Analysis of pseudogene CTNNAP1 dysregulation in colorectal cancer tissues.
  • Mechanistic studies involving microRNA-141 and competing endogenous RNA (ceRNA) interactions.
  • Gain-of-function experiments to assess the impact of CTNNAP1 and CTNNA1 overexpression on cell proliferation and tumor growth in vitro and in vivo.

Main Results:

  • Pseudogene CTNNAP1 was found to be dysregulated in colorectal cancer, with significant association with tumor node metastasis (TNM) stage.
  • CTNNAP1 regulates its cognate gene CTNNA1 through competition for microRNA-141.
  • Overexpression of CTNNAP1 or CTNNA1 inhibited colorectal cancer cell proliferation and tumor growth by inducing G0/G1 cell cycle arrest.

Conclusions:

  • A novel competing endogenous RNA (ceRNA) regulatory circuit involving pseudogene CTNNAP1 and its cognate gene CTNNA1 was identified in colorectal cancer.
  • Pseudogene CTNNAP1 plays a significant role in colorectal cancer pathogenesis.
  • CTNNAP1 presents potential as a diagnostic biomarker for monitoring human colorectal cancer.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

5.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K